Loading Curie Briefs...
Getting the latest healthcare news for you
Getting the latest healthcare news for you
A structured educational quality improvement program dramatically cut hospital-onset MRSA bloodstream infections. Across 94 US hospitals, the 18-month initiative — built around webinars, safety culture, and evidence-based practices — led to a 65% drop in MRSA bacteremia and a 31% reduction in central line-associated bloodstream infections. The results are especially notable given that national MRSA rates were still recovering from pandemic-era spikes.
A new study published in JAMA Network Open found that a structured, education-driven quality improvement program was associated with a dramatic reduction in hospital-acquired MRSA infections. The Agency for Healthcare Research and Quality's Safety Program for MRSA Prevention enrolled 94 US hospitals — spanning ICUs and non-ICUs — over 18 months (April 2022–September 2023). The program delivered 22 educational webinars and focused on building a stronger safety culture, improving environmental cleaning, and adopting evidence-based decolonization practices.
The results were striking: MRSA hospital-onset bacteremia fell by 65%, and central line-associated bloodstream infections (CLABSIs) dropped by 31%. All-cause hospital-onset bacteremia also declined significantly, with reductions driven largely by drops in MRSA, methicillin-susceptible S. aureus, and coagulase-negative Staphylococcus species — all at a time when national MRSA rates were still rebounding from pandemic-related surges.
By the Numbers:
Why it matters: MRSA infections remain a serious and costly threat in hospital settings. This study shows that a scalable, education-focused program — without requiring major new resources — can meaningfully reduce life-threatening bloodstream infections, offering a replicable model for hospitals nationwide.
